miDiagnostics is developing a next-generation diagnostic platform based on a silicon nanofluidic processor.
Midiagnostics has raised €64M across 3 funding rounds from 5 investors, most recently a Series D+ round in Dec 2024. Based in Leuven, Belgium; founded 2015; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2024-12-04 | Series D+ | €30M | Alychlo,Pamica,Thermo Fisher Scientific Inc.,VMF Invest | View deal → |
| 2021-12-09 | Debt | €20M | European Investment Bank (EIB) | View deal → |
| 2020-03-26 | Other | €14M | — | View deal → |
